Imagine swallowing a pill made from someone else's poop to beat cancer. Sounds gross, right? But scientists in Canada just proved it's not only safe—it's a potential game-changer for immunotherapy, nearly doubling response rates in tough cancers like lung and skin.NY Post
Here's what went down. Two clinical trials published in Nature Medicine last month detail how freeze-dried fecal capsules—fancy term for poop pills or LND101—worked wonders when paired with immunotherapy drugs.Nature PERFORM Trial Researchers at London Health Sciences Centre and Lawson Research Institute in London, Ontario, ran a Phase 1 trial on 20 patients with advanced kidney cancer. These folks got the capsules from healthy donors before starting standard immunotherapy like ipi/nivo. The result? Fewer brutal side effects like colitis and diarrhea that force people to quit treatment early. Responders had way less severe toxicity—only 11% hit grade 3 or worse, versus 89% of non-responders. Overall objective response rate hit 50%, solid for this high-risk group.
Then, in Montreal at CRCHUM, Dr. Arielle Elkrief's team took it further in the Phase 2 FMT-LUMINate trial.Nature LUMINate Trial They gave 20 lung cancer patients poop pills plus pembrolizumab. Boom—80% responded, compared to the usual 39-45% with immunotherapy alone. For 20 melanoma patients on nivo/ipi combo, it was 75% response versus 50-58% historically. Safety was good overall, though melanoma patients saw some quicker side effects, highlighting the need for careful donor screening.
Why does this work? Your gut microbiome is like an army influencing your immune system. Cancer immunotherapy unleashes that army on tumors, but antibiotics, diet, or dysbiosis can sabotage it with bad bacteria. The poop pills restore balance, wiping out harmful bugs like certain Clostridia or Streptococcus species while boosting good guys like Faecalibacterium. In responders, they saw sustained microbial diversity and depletion of baseline villains, leading to better T-cell action and fewer immune overreactions.[Nature Medicine studies]
This matters big time because immunotherapy doesn't work for everyone—only about half in these cancers. If poop pills can push that to 80%, we're talking longer lives, fewer dropouts from toxic side effects, and hope for hard-to-treat cases. It's already FDA-approved for C. diff infections; now expanding to pancreatic and triple-negative breast cancer trials. A big pan-Canadian randomized trial, CanBiome2, is recruiting 128 patients to confirm it. Personalized microbiome therapy could be the next frontier, screening donors to avoid risks like certain Prevotella strains that amp up toxicity.
Our take? If you're fighting cancer and this helps you stay on life-saving drugs without the gut-wrenching misery, who cares if it's poop-derived? Saman Maleki from LHSCRI called it a game-changer for side effects; Elkrief nailed the bacteria-killing mechanism. We're rooting for these London and Montreal wizards—next coffee might come with a side of science you can actually swallow. This is the kind of weird, wonderful breakthrough that makes mornings exciting.